Information between 6th January 2022 - 2nd October 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Arms Length Bodies Publications |
|---|
|
Oct. 18 2023
NICE Source Page: Ruxolitinib for treating polycythaemia vera Publication Type: Supporting evidence Document: Draft guidance consultation committee papers (PDF 8.1 MB) (webpage) Published Found: SHTAC) Authors Joanne Lord Asyl Liyakat Hawa Geoff Frampton Correspondence to Prof Joanne Lord |
|
Oct. 18 2023
NICE Source Page: Ruxolitinib for treating polycythaemia vera Publication Type: Supporting evidence Document: Final draft guidance consultation committee papers (PDF 1.52 MB) (webpage) Published Found: Assessments Centre (SHTAC) Authors Joanne Lord Geoff Frampton Correspondence to Prof Joanne Lord |
|
Oct. 04 2023
NICE Source Page: Ravulizumab for treating generalised myasthenia gravis (terminated appraisal) Publication Type: Draft guidance Document: Committee papers (PDF 7.3 MB) (webpage) Published Found: Centre (SHTAC) Authors Joanne Lord Neelam Kalita Asyl Liyakat Hawa Correspondence to Joanne Lord |
|
Sep. 14 2023
NICE Source Page: Ruxolitinib for treating polycythaemia vera Publication Type: Final draft guidance Document: Committee papers (PDF 1.51 MB) (webpage) Published Found: Assessments Centre (SHTAC) Authors Joanne Lord Geoff Frampton Correspondence to Prof Joanne Lord |
|
Jun. 02 2023
NICE Source Page: Ruxolitinib for treating polycythaemia vera Publication Type: Draft guidance Document: Committee papers (PDF 8.09 MB) (webpage) Published Found: SHTAC) Authors Joanne Lord Asyl Liyakat Hawa Geoff Frampton Correspondence to Prof Joanne Lord |